Tea

Daily tea is associated with modest but real reductions in cardiovascular events, dementia risk, and bone loss. The effect sizes are smaller than coffee's and most of the evidence is observational, but the direction is consistent across decades of cohort studies and the safety profile is excellent. The strongest single piece of recent evidence is a 2026 JAMA analysis showing 1–2 cups of tea per day associated with 18% lower dementia risk.

Tea — Camellia sinensis — is the second most-consumed beverage in the world after water, and the longevity literature on it has matured substantially over the past few years. The honest summary: tea is probably good for you, the effect sizes are smaller than coffee's, and most of the rest is observational and partly confounded by the fact that habitual tea drinkers in Western cohorts tend to be older, less likely to smoke, and more health-conscious than non-drinkers. This article walks the evidence by outcome, then by tea type, then by the practical points that matter — caffeine load, iron interaction, the green-tea-extract hepatotoxicity issue, and what to do with the L-theanine claims.

What's in a cup

Caffeine and bioactive content vary substantially by leaf processing.

TypeCaffeine (240 mL / 8 oz cup)Dominant polyphenols
Green tea25–50 mgCatechins, particularly epigallocatechin gallate (EGCG)
Black tea40–70 mgTheaflavins and thearubigins (oxidation products of catechins)
Oolong30–50 mgMixed catechins and partial oxidation products
White tea15–30 mgCatechins (less processed than green)
Matcha (whole leaf, 1 tsp)60–80 mgCatechins (higher density because the whole leaf is consumed)
Decaf tea2–5 mgCatechins and theaflavins mostly retained

Other notable constituents:

  • L-theanine — a non-protein amino acid unique to Camellia sinensis (roughly 25–60 mg per cup); crosses the blood-brain barrier and modulates glutamate, GABA, and the alpha brain waves associated with relaxed attention.
  • Tannins — a class of polyphenols that bind dietary minerals (especially non-heme iron from plant foods) in the gut. Black tea is particularly tannin-rich.
  • Fluoride — tea plants accumulate fluoride from soil; brick teas (rare in Western consumption) can deliver substantial doses.

Caffeine in tea is metabolised by the liver enzyme CYP1A2 with the same 3–6 hour half-life as in coffee, so the chronotype caveats from the Coffee article apply directly.

Mortality and health outcomes

All-cause and cardiovascular mortality

Recent large-cohort and meta-analytic data consistently show modest mortality reductions at moderate tea intake (typically defined as ~2 cups/day, with green tea benefits sometimes extending higher). Effect sizes are smaller and confidence intervals wider than for coffee, but the direction is consistent.

  • Black tea benefits for coronary heart disease tend to plateau at ~2 cups/day.
  • Green tea benefits — particularly metabolic — appear closer to linear up to ~3–4 cups/day.
  • Both caffeinated and decaffeinated tea show signal, implicating polyphenols rather than caffeine.

A common interpretive caveat applies: in Western cohorts, tea drinkers tend to be older, female, less likely to smoke, and more health-conscious; in Asian cohorts (where green tea dominates), the inverse holds in different ways. Most studies adjust for these, but residual confounding is plausible.

Dementia and cognitive decline

This is currently tea's strongest individual finding.

  • A 2026 analysis in JAMA — pooling the Nurses' Health Study and the Health Professionals Follow-Up Study, tracking 131,821 adults over 43 years of follow-up — found 1–2 cups of tea per day associated with 18% lower dementia risk, the same magnitude as 2–3 cups of caffeinated coffee. The effect held across Alzheimer's and vascular subtypes.[1]
  • Older meta-analyses report tea-associated reductions of around 12% for Alzheimer's and 25% for vascular dementia, with stronger signals for green than black tea — consistent with the 2026 finding, but methodologically weaker.
  • 2025 brain-imaging cohorts report associations between habitual green-tea intake and lower cerebral white-matter lesion burden — biologically plausible (catechin antioxidant effects on cerebrovascular endothelium) but cross-sectional and exploratory.

Type 2 diabetes and metabolic syndrome

Habitual tea consumption — typically 3–4 cups per day — is associated with modest improvements in fasting glucose, lipid profile, and blood pressure across multiple cohorts. EGCG has plausible mechanisms (it activates the cellular energy sensor AMPK, inhibits intestinal glucose absorption, and improves insulin sensitivity in vitro), but human randomised-trial effect sizes are small. Tea is useful as part of a broader dietary pattern; it is not a stand-alone metabolic intervention.

Cancer

The cancer literature on tea is genuinely mixed. Green tea catechins inhibit tumor growth in cell and animal models, and some Asian cohorts show modest reductions in stomach, breast, and prostate cancer — but Western cohorts often fail to replicate, and high-dose green tea extract supplements have been linked to rare hepatotoxicity. No strong, consistent cancer-prevention claim is supported for habitual tea drinking; treat any benefit as uncertain.

Green vs. black: does it matter?

The two are produced from the same leaf at different oxidation levels. During oxidation (which makes a tea "black"), catechins polymerize into theaflavins and thearubigins. Both classes are bioactive antioxidants, but their pharmacology differs.

  • Green tea (unoxidized): catechin-dominant. Stronger metabolic and cognitive signals in the literature. EGCG is the most-studied polyphenol in any food.
  • Black tea (fully oxidized): theaflavin-dominant. Stronger cardiovascular signal (improvements in flow-mediated dilation in RCTs); benefits plateau earlier.
  • Oolong / white / pu-erh: intermediate or specialty processing; less data, no reason to think they're inferior on safety, weak evidence base for specific outcomes.

Practical view: if you drink one or the other for taste, the difference is unlikely to matter clinically. If you're choosing for a specific reason — green tea for metabolic/cognitive, black tea for vascular — the literature mildly supports the conventional split, but mostly because that's where each was studied, not because of large head-to-head trials.

The "Successful Aging Index" green tea claim (real but heavily confounded)

A frequently cited statistic from the 2019 ATTICA/MEDIS combined analysis reports that green tea drinkers were 36–50% more likely to score above the median on the Successful Aging Index versus black tea drinkers.[2] The association is real, but the study was cross-sectional and the green tea group was also more physically active and less hypertensive at baseline. The "successful aging" outcome is plausibly driven by a cluster of healthy lifestyle habits, not by green tea per se. Useful as a directional hint, not as a quantified claim.

L-theanine: real for acute focus, speculative beyond

L-theanine has a well-documented acute effect: in small EEG and behavioral trials, it boosts alpha brain waves and partially blunts caffeine-induced jitters, producing the "relaxed alertness" that tea drinkers describe and most coffee drinkers don't get. This effect is biologically real and reasonably well-studied at the ~100–200 mg supplement-equivalent dose.

The leap that often follows in popular writing — that this acute mechanism translates into long-term neuroprotection or dementia prevention — is not supported. The dementia signal in the 2026 JAMA analysis tracked caffeine-containing tea/coffee. There's no human trial showing that the L-theanine + caffeine combination structurally protects the brain over years. Treat the acute focus benefit as the supported claim; treat long-term neuroprotection from theanine as a hypothesis.

For supplemental L-theanine specifically (sleep/anxiety dose, side effects), see Sleep supplements.

Iron and minerals

Tea is a stronger inhibitor of non-heme iron absorption than coffee — the relevant compounds are tannins (a polyphenol subclass), and black tea is denser in them than green. Co-consumed with a meal or an oral iron supplement, strong black tea can cut iron uptake substantially.

This is fully neutralized by separating tea from iron-rich meals or supplements by 60–90 minutes.[3] The interaction is local to the gut lumen — tea does not deplete stored iron in healthy people on a varied diet — but matters for menstruating women, plant-based eaters, and anyone on iron therapy. For the opposite group — adults trying to avoid lifelong iron accumulation — the same effect is a mild dietary lever rather than a drawback; see Iron and aging. See the iron section in the coffee article for the same mechanism and the alternate-day iron-dosing strategy.

Bones: a 2025 meta-analysis of coffee and tea drinkers covering roughly 560,000 adults found tea drinkers had reduced osteoporosis risk,[4] and a 2025 Flinders University cohort of women aged 65+ found higher hip bone mineral density in daily tea drinkers.[5] Polyphenol effects on the bone-resorbing osteoclasts probably outweigh the small caffeine-induced calcium loss. The net signal is mildly bone-protective.

Microbiome (plausible, mostly preclinical)

Green tea polyphenols are extensively metabolized by gut microbes and reciprocally shape microbial communities. Of particular interest is Akkermansia muciniphila, a mucin-layer commensal with strong links to metabolic health: a 2019 Nature Medicine trial showed that pasteurized Akkermansia supplementation improved insulin sensitivity and lowered cholesterol in humans.[6]

The claim that habitual green tea drinking robustly proliferates Akkermansia in humans rests mostly on animal models and observational microbiome data, not on tea-dosing trials with clinical endpoints. The biology is plausible; the human effect size for tea specifically is unestablished.

Safety considerations

  • Caffeine load. A heavy daily intake of strong tea (5+ cups of black tea or matcha) can put a sensitive person near or over the 400 mg/day caffeine limit recommended by both the European Food Safety Authority and the US FDA. In pregnancy, the 200 mg/day cap applies to total caffeine from all sources.
  • Green-tea-extract supplements. Concentrated catechin pills, often delivering ≥800 mg of EGCG per day, have caused rare cases of idiosyncratic liver injury serious enough to require transplant. Drinking tea is safe. Mega-dose green-tea-extract pills are not equivalent and not recommended.
  • Iron interaction — see above; matters only for those with marginal iron status (menstruating women, plant-based eaters, anyone on iron therapy).
  • Fluoride. Typical brewed tea contributes a small amount of dietary fluoride. Brick tea (rare outside parts of Tibet and Mongolia) can deliver doses high enough to cause skeletal fluorosis with chronic use.
  • Drug interactions. Green-tea catechins can reduce absorption of the beta-blocker nadolol and some related drugs; supplemental EGCG can interact with some chemotherapies and with warfarin. Drinking tea with a meal away from medications avoids most issues.

Practical recommendations

  1. 2–3 cups per day of green or black tea is the dose where most cohort signals converge. Higher (3–4 cups) is fine if tolerated, especially for green tea.
  2. Match tea to taste, not to a specific health claim. The green-vs-black difference in the literature is real but small; the larger benefit comes from drinking tea regularly versus not.
  3. Time around iron-rich meals or supplements if iron status matters to you (60–90 min separation).
  4. Caffeine timing is the same as coffee: avoid within 8–10 hours of bedtime if you're a sensitive sleeper.
  5. Don't take green tea extract pills for longevity. Drink tea instead.
  6. Pregnancy: count tea toward the 200 mg/day caffeine ceiling.
  7. Don't start drinking tea purely for health benefits if you don't enjoy it — the effect sizes don't justify adoption against preference.

Further reading

  • Coffee and tea consumption and dementia incidence — Nurses' Health Study and Health Professionals Follow-Up Study. JAMA 2026 (131,821 adults, 43-year follow-up).[7]
  • Hu et al. Coffee and tea consumption and osteoporosis — meta-analysis. 2025.[8]
  • Ahmad Fuzi SF et al. Tea timing and iron absorption. Am J Clin Nutr 2017.[9]
  • Green and black tea and the Successful Aging Index — ATTICA / MEDIS combined analysis. 2019.[10]
  • Depommier C et al. Pasteurised Akkermansia muciniphila in human metabolic syndrome. Nat Med 2019.[11]
  • Tea and bone density in older women — Flinders University cohort. 2025.[12]

For coffee-specific evidence (caffeine pharmacology, CYP1A2 metabolism, filtered-vs-unfiltered, microbiome, dementia), see Coffee →.


— § —